Multiple Sclerosis Journal

Titel Veröffentlichungsdatum Sprache Zitate
Reply to the letter: Biotinidase deficiency masquerading as multiple sclerosis?2017/03/24English
Reviewer List 20162017/03/01English
Response to letter regarding article ‘Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder’2016/08/19English
Visualization of cortical MS lesions with MRI need not be further improved – Commentary2016/09/28English
Clinical commentary on ‘Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis’2018/02/23English
Reporting suspected adverse reactions to new commercialized medicines in real world2018/01/23English
William A. Sibley (1925–2015): Clinical researcher, diagnostician, champion of interdisciplinary neuroscience2016/09/28English
Re: Declines in the diagnosis of primary progressive MS—A critical change in phenotype or critical measurement error?2016/09/28English
Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation—A study from the neuro-urology committee of the French Association of Urology2023/06/02English
Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis2023/05/18English
ACTRIMS Forum 2023 Author Index2023/05/01English
ACTRIMS Forum 20232023/05/01English
Letter to the editor: Mobile health interventions in multiple sclerosis: A systematic review2024/03/11English
Iatrogenic myelodysplastic syndrome complicating multiple sclerosis: A case report2024/03/08English
Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis2024/02/28English
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis2024/03/08English
Expert opinion on the use of contraception in people with multiple sclerosis2024/03/08English
Reply: Mobile health interventions in multiple sclerosis: A systematic review2024/02/29English
Psoriasiform dermatitis following ocrelizumab in relapsing-remitting multiple sclerosis: Case report and literature review2024/02/22English
Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis2024/02/22English
Tick-borne illnesses in patients treated with B-cell depleting agents: Considerations for neurologists2024/03/07English
Efficacy and safety results after >3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study2024/03/04English
Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial2024/03/01English
Increased levels of circulating soluble CD226 in multiple sclerosis2024/02/29English
BCG vaccination and multiple sclerosis risk: A Norwegian cohort study2024/02/27English
T1/T2-weighted ratio: A feasible MRI biomarker in multiple sclerosis2024/02/22English
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas2024/02/22English
Neurofilament in clinical practice: Is the multiple sclerosis community ready?2024/04/11English
Drug-induced lymphopenia: Are all fumarates the same?2024/04/11English
New onset lymphopenia in patients with relapsing multiple sclerosis switching from long-standing dimethyl fumarate treatment to diroximel fumarate: A case series2024/04/11English